We report our first clinical use of the new Protek DuoTM cannula for peripheral veno-venous extra-corporeal life support (ECLS). A 53-year-old male patient underwent implantation of a total artificial heart (TAH) for biventricular failure. However, due to the development of post-operative respiratory dysfunction, the patient required ECLS for six days.
SlepianMJAlemuYGirdharG. The Syncardia total artificial heart: in vivo, in vitro, and computational modelling studies. J Biomech2013; 46: 266–275.
2.
TorregrossaGAnyanwuAZucchettaFGerosaG. SynCardia: the total artificial heart. Ann Cardiothorac Surg2014; 3: 612–620.
3.
BehrensLGGoodaleNLTurekJWBatesMJ. Use of pulmonary arteriovenous extracorporeal membrane oxygenation in conjunction with the total artificial heart. Perfusion2016; 31: 87–88.
4.
CopelandJGCopelandHGustafsonM. Experience with more than 100 total artificial heart implants. J Thorac Cardiovasc Surg2012; 143: 727–734.
5.
MiessauJYangQUnaiSEntwistleJWCavarocchiNCHiroseH. Veno-venous extracorporeal membrane oxygenation using a double-lumen bi-caval cannula for severe respiratory failure post total artificial heart implantation. Perfusion2015; 30: 410–414.
BromanMFrencknerBBjällmarkABrooméM. Recirculation during veno-venous extra-corporeal membrane oxygenation – a simulation study. Int J Artif Organs2015; 38: 23–30.
8.
JavidfarJDoganGGuersoyDSerranoMRKoerferRTenderichG. Use of bicaval dual lumen catheter for adult veno-venous extracorporeal membrane oxygenation. Ann Thorac Surg2011; 91: 1763–1768.
9.
SpiliopoulosSDoganGGuersoyDSerranoMRKoerferRTenderichG. Veno-venous extracorporeal membrane oxygenation with a bicaval dual-lumen catheter in a SynCardia total artificial heart patient. J Cardiothorac Surg2013; 8: 179.
